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Abstract The NS3 protein of Japanese encephalitis virus (JEV)
contains motifs typical of RNA helicase/NTPase but no RNA
helicase activity has been reported for this protein. To identify
and characterize the RNA helicase activity of JEV NS3, a
truncated form of the protein with a His-tag was expressed in
Escherichia coli and purified. The purified JEV NS3 protein
showed an RNA helicase activity, which was dependent on
divalent cations and ATP. An Asp-285-to-Ala substitution in
motif II of the JEV NS3 protein abolished the ATPase and RNA
helicase activities. These results indicate that the C-terminal 457
residues are sufficient to exhibit the RNA helicase activity of
JEV NS3.
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1. Introduction
Japanese encephalitis virus (JEV) is an arthropod-borne
£avivirus and is a causative agent of central nervous diseases
such as meningitis and severe encephalitis [1]. JEV belongs to
the genus £avivirus of the family Flaviviridae. JEV has a
positive, single-strand RNA genome of about 11 kb in length
and the genome RNA is translated into a single polyprotein
precursor which is subsequently processed to produce three
structural (C, M and E) and seven non-structural (NS1,
NS2A, NS2B, NS3, NS4A, NS4B and NS5) proteins.
The £avivirus NS3 protein is a multifunctional protein,
which possesses several enzymatic activities. The serine pro-
tease activity was identi¢ed within about one fourth of the N-
terminal domain of the NS3 protein of £aviviruses [2^4]. The
remaining C-terminal region of the NS3 protein contains typ-
ical sequence motifs presumably responsible for NTP binding,
NTP hydrolysis and RNA helicase. Among £aviviruses, an
RNA-stimulated nucleoside triphosphatase (NTPase) activity
was identi¢ed in the NS3 proteins of yellow fever virus, West
Nile virus, dengue virus and JEV [4^9]. To date, however, the
RNA helicase activity of £avivirus was demonstrated only in
the NS3 protein of dengue virus type 2 [4]. The RNA-stimu-
lated NTPase and RNA helicase activities were also identi¢ed
in the NS3 proteins of viruses which are genetically related to
£avivirus such as hepatitis C virus (HCV), hepatitis G virus
(HGV) and bovine viral diarrhea virus, a pestivirus (BVDV)
[10^19]. The roles of such enzymatic activities of the £avivirus
NS3 protein in viral replication are poorly understood.
In this study, we demonstrated that an N-terminally trun-
cated form of the JEV NS3 protein expressed in Escherichia
coli has an RNA helicase activity. The optimal enzymatic
activity of the JEV NS3 helicase has been studied. Moreover,
the site-directed mutagenesis at Asp-285 in motif II has re-
vealed that this residue is essential not only for RNA-stimu-
lated ATPase activity but also for the RNA helicase activity.
2. Materials and methods
2.1. Construction of NS3 expression plasmids
A cDNA fragment was ampli¢ed using a sequence derived from the
Japanese JEV strain JaO0566. PCR ampli¢cation was carried out
using the primers 5P-TCG AAT TCC AGC GCC ATC GTG CAG-
3P and 5P-ACG TCG ACT CTC TTT CCT GCT GC-3P. The 1.4 kb
PCR-ampli¢ed DNA fragment was digested with EcoRI and SalI, and
cloned into the corresponding restriction site of pET-21b (Novagen,
Madison, WI, USA). The expression plasmid encodes amino acids
163^619 of the JEV NS3 protein with a His-tag at the C-terminus.
As a positive control for the enzymatic activities of the JEV NS3
protein, we constructed a truncated form of the recombinant HCV
NS3 protein as reported previously [20].
2.2. Expression and puri¢cation of NS3 proteins
The expression plasmids containing JEV and HCV NS3 genes were
independently transformed into E. coli BL21(DE3)pLysS cells (Stra-
tagene, La Jolla, CA, USA). After the IPTG induction at 37‡C for 3 h,
the cells were collected by centrifugation. The cells were resuspended
in bu¡er B (10 mM Tris^HCl bu¡er (pH 8.5), 100 mM NaCl, 0.25%
Tween 20) and disrupted by sonication for 5 min on ice. The soluble
fraction of the clari¢ed cell lysate was mixed with TALON metal
a⁄nity resin (Clontech, Palo Alto, CA, USA). After gentle mixing
for 1 h at 4‡C, the resin was collected by a brief centrifugation and
washed with bu¡er B. Resin-bound protein was eluted with 2 volumes
of bu¡er B containing 400 mM imidazole. Eluted protein fractions
were dialyzed against dialysis bu¡er (10 mM Tris^HCl (pH 8.5),
100 mM NaCl, 10% Glycerol) at 4‡C. Puri¢ed JEV and HCV NS3
proteins were designated NS3JEV-wild and NS3HCV-wild, respec-
tively.
2.3. Site-directed mutagenesis
Site-directed mutation was introduced by QuikChange Site-Di-
rected Mutagenesis kit (Stratagene) according to the manufacturer’s
instruction. The nucleotide sequence of the entire coding region was
determined and the desired mutation was con¢rmed. The mutant
plasmid was transformed into E. coli BL21(DE3)pLysS cells and the
resultant mutant protein was designated NS3JEV-AEAH.
2.4. Preparation of the substrate for RNA helicase assay
The 32P-labeled RNA fragment was synthesized by the Riboprobe
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System-T7 (Promega, Madison, WI, USA) using a pSP72 DNA frag-
ment linearized with BamHI as a template DNA. Plasmid pGEM-
3Zf(+) (Promega) was linearized with EaeI and was used to prepare
a non-radiolabeled RNA fragment. The RNA transcripts were resus-
pended together in 100 Wl of annealing bu¡er (10 mM Tris^HCl (pH
8.5), 100 mM NaCl, 8 fmol of each transcript), and were hybridized
by boiling for 5 min and then incubated at room temperature over-
night.
2.5. RNA helicase assay
The RNA helicase assay was carried out in 20 Wl of helicase bu¡er
containing 25 mM MES (pH 6.0), 2 mM DTT, 2 mM MgCl2, 5 mM
ATP, 1.25 units of RNase inhibitor (Promega), 0.32 fmol of the RNA
substrate and the puri¢ed NS3 protein. The reaction mixture was
incubated at 37‡C for 30 min, and 5 Wl of loading bu¡er (100 mM
Tris^HCl (pH 7.4), 5 mM EDTA, 0.5% SDS, 50% glycerol, 0.1%
xylene cyanol, 0.1% bromophenol blue) was added to terminate the
reaction. A 10 Wl loading mixture was analyzed by 10% native poly-
acrylamide gel electrophoresis. The autoradiographic pattern was ob-
tained with the BAS 2000 Image Analyzing System (Fuji Photo Film,
Tokyo, Japan) and the labeled RNA was quanti¢ed using MacBAS
software (Fuji Photo Film).
2.6. Colorimetric ATPase assay
The amount of free phosphate moiety released from ATP was
measured as described previously [21]. Brie£y, 50 Wl/well of reaction
mixture containing 10 mM MOPS bu¡er (pH 6.5), 2 mM ATP, 1 mM
MgCl2, and puri¢ed NS3 protein (0.8 pmol) was incubated in a 96
well microtiter plate at room temperature for 30 min. The reaction
was stopped by adding 100 Wl/well of dye solution (water:0.081%
malachite green:5.7% ammonium molybdate in 6 N HCl:2.3% poly-
vinyl alcohol = 2:2:1:1, v/v). After the addition of 25 Wl/well of 30%
sodium citrate, the absorbance at 620 nm with a reference wavelength
at 492 nm was measured.
3. Results
3.1. Expression and puri¢cation of the truncated JEV NS3
protein
To identify and characterize the helicase activity of JEV
NS3, we prepared an expression plasmid spanning 457 amino
acids of the C-terminus of JEV NS3. Similarly, the corre-
sponding region of the HCV NS3 gene was subcloned into
the pET-21b vector, and the recombinant HCV NS3 protein
was also expressed in E. coli as a positive control for the
helicase activity. The SDS^PAGE analysis indicated that the
puri¢ed JEV and HCV NS3 proteins were 54 kDa (Fig. 1,
lanes 2 and 4). The puri¢ed NS3JEV-wild protein had an
ATPase activity which was signi¢cantly stimulated by poly(U)
(data not shown) as reported previously [8].
3.2. RNA helicase activity of the JEV NS3 protein
For RNA helicase assay, we used an RNA substrate con-
taining a partially double-stranded region (22 bp) and both 5P
and 3P single-stranded overhanging sequences (Fig. 2A). An
unwinding activity of the RNA substrate was demonstrated in
1^4 pmol puri¢ed NS3JEV-wild protein (Fig. 2B, lanes 6^8).
As shown in Fig. 2B, decreased RNA unwinding activities
were observed in the reactions with 4^8 pmol of the JEV
NS3 protein. The slower migration rate of labeled dsRNA
in lanes 7 and 8 suggests that any protein-RNA complex still
remained after the addition of SDS sample bu¡er to the re-
actions with higher concentrations of the protein. A similar
potent a⁄nity for dsRNA was recently reported for a mutant
HCV NS3 helicase [22]. In the absence of ATP (lane 6) or
MgCl2 (lane 7), no RNA helicase activity was demonstrated
in the JEV NS3 protein (Fig. 3). In this assay, an identical
amount (2 pmol) of the NS3HCV-wild protein (Fig. 3, lane 3),
which served as a positive control, showed more RNA heli-
case activity than the JEV NS3 protein (lane 5).
3.3. Characterization of the RNA helicase of the JEV NS3
protein
To characterize the RNA helicase activity of the puri¢ed
JEV NS3 protein, an RNA unwinding activity was examined
Fig. 1. SDS^PAGE analysis of puri¢ed JEV and HCV NS3 pro-
teins. Each puri¢ed protein (2 Wg/lane) was subjected to SDS^
PAGE, and the gel was stained with Coomassie blue. Lane 1, mo-
lecular weight marker; Lane 2, NS3JEV-wild; Lane 3, NS3JEV-
AEAH mutant; Lane 4, NS3HCV-wild.
Fig. 2. RNA helicase assay of the wild-type JEV NS3. A: Partially
double-stranded RNA substrate for the helicase assay. B: RNA
helicase assays were performed as described in Section 2. Lane 1,
boiled RNA substrate; Lane 2, untreated RNA substrate (negative
control); Lanes 3^9, an RNA helicase assay was performed with in-
creasing concentrations (0, 0.25, 0.5, 1, 2, 4 and 8 pmol) of puri¢ed
JEV NS3 protein.
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in various assay conditions. As shown in Fig. 4A, the RNA
helicase activity was dependent on the divalent cations, and
the optimal concentrations of Mg2 and Mn2 were 2 mM
and 3 mM, respectively. On the other hand, increasing con-
centrations of potassium ion inhibited the RNA helicase ac-
tivity. A similar phenomenon was reported for HCV NS3 and
BVDV p80 helicases [12,14,17,18]. Increasing concentrations
of Ca2 also decreased the RNA helicase activity of JEV NS3
(Fig. 4C). The optimal pH of JEV NS3 helicase was 6.0 (Fig.
4D) which was slightly lower than that of HCV and BVDV
helicases, 7.0 and 6.5, respectively [12,14,17,18]. The RNA
helicase activity of JEV NS3 required ATP and the optimal
ATP concentration was 5 mM in the presence of 2 mM
MgCl2 (Fig. 4E). Higher concentrations of ATP (up to
8 mM) had an inhibitory e¡ect as reported for the adeno-
Fig. 3. RNA helicase assay of the wild-type and mutant NS3 pro-
teins. RNA helicase assays were performed as described in Section 2
with 4 pmol of each puri¢ed protein. Lane 1, boiled RNA sub-
strate; Lane 2, untreated RNA substrate; Lane 3, NS3HCV-wild;
Lane 4, NS3JEV-AEAH mutant; Lane 5, NS3JEV-wild; Lane 6,
NS3JEV-wild without ATP; Lane 7, NS3JEV-wild without MgCl2.
The amount of labeled RNA released from the boiled substrate was
set as 100%.
6
Fig. 4. Characterization of JEV NS3 helicase. The RNA helicase activity of wild-type JEV NS3 was assayed in the standard helicase reaction
mixture with 2 pmol of the NS3JEV-wild protein. A: Optimization of the concentration of MgCl2 or MnCl2 in the presence of 3 mM ATP.
B: E¡ect of KCl concentration in the presence of 2 mM MgCl2. C: E¡ect of CaCl2 concentration in the presence of 2 mM MgCl2. D: Optimi-
zation of pH. E: E¡ect of ATP concentration. F: Optimization of the reaction temperature.
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associated virus Rep68 helicase [23]. The helicase activity of
JEV NS3 could be detected at 37^45‡C, and the optimal tem-
perature for the reaction was 40‡C (Fig. 4F). In conclusion,
the truncated form of the JEV NS3 protein showed similar
enzymatic characteristics to those previously described for
HCV NS3 and BVDV p80 helicases.
3.4. Mutagenesis at Asp-285 in motif II of JEV NS3
To con¢rm the intrinsic RNA helicase activity of a trun-
cated form of the JEV NS3 protein, we have introduced an
alanine-substitution at Asp-285 in motif II which is presum-
ably one of the most important sequence motifs for the NTP
hydrolysis. The puri¢ed NS3JEV-AEAH mutant protein (Fig.
1, lane 3) exhibited no detectable ATPase activity (data not
shown). The NS3JEV-AEAH mutant protein showed no
RNA helicase activity (Fig. 3, lane 4), indicating that the
Asp-to-Ala substitution completely abolished both enzymatic
activities. The result also con¢rms that the apparent RNA
helicase activity is due to the NS3JEV-wild protein rather
than contaminated proteins derived from the bacterial cell
lysates.
4. Discussion
Although RNA-stimulated NTPase and RNA binding ac-
tivities of JEV NS3 has been identi¢ed using recombinant
NS3 proteins expressed in E. coli, an RNA helicase activity
has not been detected [7,8]. In the present study, we showed
that the truncated form of the JEV NS3 protein possessed an
RNA helicase activity as well as the poly(U)-stimulated ATP-
ase activity.
Recently, the NS3 protein of dengue virus type 2, one of the
arthropod-borne £aviviruses, was shown to possess RNA heli-
case activity, together with serine protease and RNA-stimulat-
ing NTPase activities by using the recombinant proteins ex-
pressed in E. coli [4]. However, biochemical characterization
of the RNA helicase has not been described. Moreover, the
truncated NS3 protein of dengue virus has been shown to
exhibit signi¢cantly weaker RNA helicase activity than that
reported previously for HCV NS3 helicase and for BVDV p80
helicase [12,14,20,24]. Up to 27 pmol of the puri¢ed NS3
protein of dengue virus was required before it exhibited
weak but detectable RNA helicase activity [4]. In this study,
however, 1^4 pmol of a truncated form of the JEV NS3 pro-
tein had obvious RNA helicase activity (Fig. 2). The di¡er-
ence of apparent RNA helicase activities between the NS3
proteins of dengue virus and JEV may be due to the way
each protein was puri¢ed. To purify and characterize the re-
combinant NS3 proteins of dengue virus the proteins from
insoluble fractions, expressed in E. coli, were puri¢ed in the
presence of 6 M guanidine, and renatured to active form after
their puri¢cation [4]. In this study, we have puri¢ed the trun-
cated forms of wild and mutant JEV NS3 proteins directly
from soluble fractions expressed in E. coli BL21(DE3)pLysS.
By using such a simpli¢ed puri¢cation system, a more detailed
characterization of the RNA helicase activity of JEV NS3 has
become possible. Another possible explanation for higher
RNA helicase activity of JEV NS3 is that the reaction con-
dition was not optimal for the dengue NS3 helicase. The op-
timization for the helicase activity of dengue NS3 has not
been described [4].
The £avivirus NS3 protein contains GKT/S (motif I) and
DExH (motif II) motifs which are commonly found in the
DExH protein subfamily of the DEAD-box protein family
[25^27]. From the crystal structure of HCV NS3, it appears
that motif II interacts with motif I which forms a phosphate-
binding loop [28^30]. The side chains of the residues in motif
II may be involved in binding L-phosphate of ATP and Mg2
which presumably make a complex with L and Q phosphates
of the ATP molecule. Mutational and crystallographic analy-
ses of HCV NS3 also suggest that motif II is involved in the
coupling of the ATPase and RNA helicase activities via con-
formational changes of the NTP-binding pocket [18,24,31].
However, for £avivirus NS3 proteins including JEV NS3,
the crystal structure has not been solved and no mutational
analysis has been so far reported. The mutagenesis at Asp-285
in this study implies that the residue is essential for both
ATPase and RNA helicase activities. For other DExH heli-
cases, a corresponding Asp-to-Ala substitution in motif II was
shown to cause severe defects in RNA unwinding and ATPase
activities [18,32,33]. Further mutational analysis of JEV NS3
will address the contribution of each domain to the ATP
hydrolysis, RNA binding and RNA helicase activities. The
expression and puri¢cation system for the JEV NS3 protein
described in this study will provide useful material for such
biochemical studies.
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